PlaqueTec Appoints CMO
This article was originally published in Scrip
Executive Summary
Cambridge-based PlaqueTec, a company focused on coronary heart disease, has appointed Dr. Nick West chief medical officer. West is a consultant interventional cardiologist at Papworth Hospital, Cambridge, and a research-active clinician. Previously he has been clinical lead for interventional cardiology at Papworth, deputy chair of the British Cardiovascular Society acute cardiac care working group and a member of the guidelines and clinical practice committee. He has also acted as an expert advisor to NICE.
You may also be interested in...
Text Mining And Machine Reading: The Answer To Pharma's R&D Data Mountain?
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Adherence Issues Add Weight To Digital Trials Push
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.